華夏幸福(600340.SH):下屬公司廊坊市孔雀城擬受讓涇陽裕鼎49%股權
格隆匯7月5日丨華夏幸福(600340.SH)公佈,公司基於目前“保交樓”經營需要,為推動下屬公司更好地履行合作協議,增強對合作建設項目的控制權,擬由下屬公司回購合作方持有的項目公司股權,以實現合作方從項目公司退出的目的。公司下屬公司廊坊市孔雀城擬與合作方澤川鼎龍、天恒尚德及相關方廊坊京御、涇陽裕鼎簽署《股權轉讓協議》,約定廊坊市孔雀城受讓澤川鼎龍及天恒尚德合計持有的涇陽裕鼎49%股權,交易價款為人民幣5,586萬元。本次交易完成後公司下屬公司廊坊京御及廊坊市孔雀城合計持有涇陽裕鼎100%股權。截至目前,涇陽裕鼎在開發項目已完成交付,剩餘工作尚在推進中。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.